文献速递神经CT

基于ASPECTS的净水摄取量在晚期时间窗急性缺血性卒中患者预后预测中优于目标错配

ASPECTS-based net water uptake outperforms target mismatch for outcome prediction in patients with acute ischemic stroke and late therapeutic window.
PubMed 文献 · Eur Radiol · 2023-07-27

本研究纳入109例发病6-24小时的前循环大血管闭塞急性缺血性卒中患者,比较基于ASPECTS的净水摄取量(ASPECTS-NWU)与CT灌注目标错配对90天良好预后的预测价值。结果显示ASPECTS-NWU的AUC为0.738,优于目标错配的0.583(p=0.004),且是唯一与良好预后独立相关的神经影像标志物(OR 0.73,95%CI 0.62-0.87,p<0.001)。作者认为ASPECTS-NWU可能成为晚期时间窗患者筛选的替代影像生物标志物。

要点

  • ASPECTS-NWU越高,CT灌注上的缺血核心和低灌注体积越大(r=0.66和r=0.38,p<0.001)。
  • ASPECTS-NWU预测90天良好预后的AUC为0.738,优于目标错配的0.583(p=0.004)。
  • ASPECTS-NWU联合NIHSS评分和年龄的模型AUC为0.828(95%CI 0.744-0.893)。

核心结论

  • 在晚期时间窗急性缺血性卒中患者中,ASPECTS-NWU对预后的预测优于CT灌注目标错配,可能成为替代CT灌注用于患者筛选的影像生物标志物。

研究设计与样本

  • 研究为连续纳入109例前循环大血管闭塞、发病6-24小时的急性缺血性卒中患者,从入院CT计算自动化ASPECTS-NWU,并与CT灌注参数比较预后预测能力。

关键影像表现/征象

  • ASPECTS-NWU水平越高,CT灌注上的缺血核心越大(r=0.66,p<0.001)。
  • ASPECTS-NWU水平越高,CT灌注上的低灌注体积越大(r=0.38,p<0.001)。

诊断标准与关键数值

  • 目标错配定义为缺血核心<70 mL、错配比≥1.8且绝对差值≥15 mL。
  • ASPECTS-NWU预测90天良好预后(mRS≤2)的AUC为0.738,目标错配的AUC为0.583(p=0.004)。
  • ASPECTS-NWU与良好预后独立相关(OR 0.73,95%CI 0.62-0.87,p<0.001)。
  • ASPECTS-NWU联合NIHSS评分和年龄的模型AUC为0.828(95%CI 0.744-0.893),敏感度65.4%,特异度87.7%。

临床应用与阅片要点

  • 作者认为ASPECTS-NWU可能作为CT灌注目标错配的替代影像生物标志物,用于晚期时间窗急性缺血性卒中患者的筛选。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To compare the prognostic value of net water uptake (NWU) and target mismatch (TM) on CT perfusion (CTP) in acute ischemic stroke (AIS) patients with late time window.

METHODS: One hundred and nine consecutive AIS patients with anterior-circulation large vessel occlusion presenting within 6-24 h from onset/last seen well were enrolled. Automated Alberta Stroke Program Early CT Score-based NWU (ASPECTS-NWU) was calculated from admission CT. The correlation between ASPECTS-NWU and CTP parameters was assessed. Predictors for favorable outcome (modified Rankin Scale score ≤ 2) at 90 days were assessed using logistic regression analysis. The ability of outcome prediction between ASPECTS-NWU and TM (an ischemic core < 70 mL, a mismatch ratio ≥ 1.8, and an absolute difference ≥ 15 mL) was compared using receiver operating characteristic (ROC) curve.

RESULTS: A higher level of ASPECTS-NWU was associated with a larger ischemic core (r = 0.66, p < 0.001) and a larger hypoperfusion volume (r = 0.38, p < 0.001). ASPECTS-NWU performed better than TM for outcome stratification (area under the curve [AUC], 0.738 vs 0.583, p = 0.004) and was the only independent neuroimaging marker associated with favorable outcomes compared with CTP parameters (odds ratio, 0.73; 95% confidence interval [CI] 0.62-0.87, p < 0.001). An outcome prediction model including ASPECTS-NWU and clinical variables (National Institutes of Health Stroke Scale scores and age) yielded an AUC of 0.828 (95% CI 0.744-0.893; sensitivity 65.4%; specificity 87.7%).

CONCLUSION: ASPECTS-NWU performed better than TM for outcome prediction in AIS patients with late time window and might be an alternative imaging biomarker to CTP for patient selection.

CLINICAL RELEVANCE STATEMENT: Automated Alberta Stroke Program Early CT Score-based net water uptake outperforms target mismatch on CT perfusion for the outcome prediction in patients with acute ischemic stroke and can be an alternative imaging biomarker for patient selection in late therapeutic window.

KEY POINTS: • A higher ASPECTS-based net water uptake was associated with larger ischemic cores and hypoperfusion volumes on CT perfusion. • ASPECTS-based net water uptake outperformed target mismatch for outcome prediction in acute ischemic stroke with extended therapeutic window. • ASPECTS-based net water uptake can be an alternative biomarker to target mismatch for selecting acute ischemic stroke patients with late therapeutic window.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Wu RR, Cao YZ, Xu XQ, et al. ASPECTS-based net water uptake outperforms target mismatch for outcome prediction in patients with acute ischemic stroke and late therapeutic window. Eur Radiol. 2023. PMID: 37498384. doi:10.1007/s00330-023-09965-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。